Different Journeys. Shared Patterns. Real Support.

For too long, women’s ADHD symptoms have been overlooked, masked, or brushed off. We want to change that narrative – we’re flipping the script and bringing awareness to what women with ADHD face. Actress Busy Philipps and professional snowboarder Chloe Kim are sharing their unique experiences with ADHD, empowering other women to advocate for treatment and care.

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older

Chloe Kim and Busy Philipps are actual Qelbree patients and paid spokespeople. Intended for U.S. audiences only.

Owning Her Patterns: Chloe’s Journey to Ms. Represented

Navigating ADHD behind the scenes

Off the mountain, many people didn’t see what it took for her to keep up with everyday tasks. After talking to her doctor, she learned that her experiences were not personality flaws—they were patterns of how ADHD can show up in women.

Chloe hopes that her journey empowers other women to recognize their own symptoms—which often present differently in women vs. men—and have an open conversation with their doctor about a treatment plan.

Watch Chloe’s journey to finding once-a-day, non-stimulant Qelbree that offers full-day coverage.

For such a long time, women’s ADHD symptoms have been dismissed as personality flaws, leaving so many of us undiagnosed and unsupported. I’m sharing my story so other women and girls know they aren’t alone.”

Chloe Kim Professional snowboarder

Does this sound like you? It’s time to get real with your doctor about your ADHD.

Feel confident at your next appointment with tips and tricks for talking to your doctor about the realities of ADHD and how to help manage it.

Because when you find a treatment plan that fits your life, you too can step out from behind the mask and be Ms. Represented.

Start the Conversation

Navigating the Overwhelm: Busy’s “Aha” Moment

From feeling like “too much” to feeling understood

For much of her life, Busy thought she was just “too loud” or “too disorganized.” It wasn’t until her daughter was diagnosed with ADHD that she realized she was experiencing similar symptoms. Receiving a diagnosis in adulthood gave Busy clarity and self-compassion as she balanced the demands of her career and motherhood.

Discover Busy’s journey to receiving an ADHD diagnosis from her doctor and finding Qelbree.

People assume ADHD is just hyper little kids bouncing off the walls. But for so many women, it’s being overwhelmed, getting easily distracted, or not knowing where to start – like having a million tabs open all at once."

Busy Philipps Actor, author, and parent

ADHD in Women is Often Misunderstood

Women with ADHD may be called out for:

Being overwhelmed
Being chronically disorganized
Exhibiting poor time management/chronic lateness
Experiencing low self-esteem
Finding it difficult to manage daily activities or chores

During 2020–2022, boys had a higher prevalence of ADHD diagnosis (~15%) than girls (8%).

Many women don’t receive an ADHD diagnosis until their late 30s or 40s, sometimes prompted by their child’s diagnosis.
The percentage of women newly diagnosed with ADHD between 23-29 and 30-49 years of age nearly doubled from 2020 to 2022.

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE